RCM
BPMC

RA Capital Management’s Blueprint Medicines BPMC Stock Holding History

RA Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-56,442
Closed -$1.02M – 34
2016
Q1 		$1.02M Sell
56,442
-821,906
-94% -$14.3M 0.13% 40
2015
Q4 		$23.1M Hold
878,348
– – 2.29% 14
2015
Q3 		$18.7M Hold
878,348
– – 2.69% 15
2015
Q2 		$23.3M Buy
+878,348
New +$25.1M 2.34% 15

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RA Capital Management's BPMC Position: Q2 2016 in Review

RA Capital Management sold out of Blueprint Medicines (BPMC) in Q2 2016, closing a stake of 56,442 shares — an estimated $1.02M sold.

RA Capital Management first reported a position in BPMC in Q2 2015 and held it in 4 quarters. The position peaked at $23.3M in Q2 2015. 82 funds tracked by Wall St. Rank hold BPMC as of Q2 2016.

  • RA Capital Management reported no remaining Blueprint Medicines position as of Q2 2016 after selling out during the quarter.
  • RA Capital Management sold 56,442 Blueprint Medicines shares in Q2 2016, an estimated $1.02M.
  • RA Capital Management first reported a position in Blueprint Medicines in Q2 2015 and held it in 4 quarters.
  • RA Capital Management's Blueprint Medicines position peaked at $23.3M in Q2 2015.
  • 82 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2016.

Based on RA Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.